These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2029417)

  • 1. Adjuvant endocrine treatment in early prostatic cancer.
    Schröder FH
    Acta Oncol; 1991; 30(2):255-8. PubMed ID: 2029417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone therapy of prostatic bone metastases.
    Huben RP
    Adv Exp Med Biol; 1992; 324():305-16. PubMed ID: 1492625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Problems and principles of hormone therapy of advanced prostate cancer].
    Altwein JE; Faul P
    Klin Wochenschr; 1990 Apr; 68(7):347-58. PubMed ID: 1692896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer].
    Mottet N; Bellmunt J; Bolla M; Joniau S; Mason M; Matveev V; Schmid HP; van der Kwast T; Wiegel T; Zattoni F; Heidenreich A
    Actas Urol Esp; 2011; 35(10):565-79. PubMed ID: 21757258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocrine treatment of prostate cancer.
    Tammela T
    J Steroid Biochem Mol Biol; 2004 Nov; 92(4):287-95. PubMed ID: 15663992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocrine prevention and treatment of prostate cancer.
    Tammela TL
    Mol Cell Endocrinol; 2012 Sep; 360(1-2):59-67. PubMed ID: 22465099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early versus deferred androgen suppression in the treatment of advanced prostatic cancer.
    Nair B; Wilt T; MacDonald R; Rutks I
    Cochrane Database Syst Rev; 2002; (1):CD003506. PubMed ID: 11869665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease progression and survival in patients with prostate carcinoma and positive lymph nodes after radical retropubic prostatectomy.
    Kroepfl D; Loewen H; Roggenbuck U; Musch M; Klevecka V
    BJU Int; 2006 May; 97(5):985-91. PubMed ID: 16643480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Usefulness of initial chemoendocrine therapy for advanced prostate cancer].
    Kanetake H; Igawa T; Sakai H; Saito Y
    Nihon Rinsho; 1998 Aug; 56(8):2173-6. PubMed ID: 9750529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Radiation therapy with neoadjuvant hormonal therapy for prostate cancer confined to pelvis].
    Furuya Y; Akakura K; Ito H
    Nihon Rinsho; 1998 Aug; 56(8):2181-4. PubMed ID: 9750531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical stage T3 prostate cancer: natural history, therapeutic choices and their results].
    Peneau M; Piéchaud T; Cariou G; Ragni E; Fontaine E; Fournier G
    Prog Urol; 1998 Dec; 8(6):977-93. PubMed ID: 9894256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early endocrine therapy versus radical prostatectomy combined with early endocrine therapy for stage D1 prostate cancer.
    Schmeller N; Lubos W
    Br J Urol; 1997 Feb; 79(2):226-34. PubMed ID: 9052475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized trial comparing radical prostatectomy plus endocrine therapy versus external beam radiotherapy plus endocrine therapy for locally advanced prostate cancer: results at median follow-up of 102 months.
    Akakura K; Suzuki H; Ichikawa T; Fujimoto H; Maeda O; Usami M; Hirano D; Takimoto Y; Kamoto T; Ogawa O; Sumiyoshi Y; Shimazaki J; Kakizoe T;
    Jpn J Clin Oncol; 2006 Dec; 36(12):789-93. PubMed ID: 17082219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Radical prostatectomy and adjuvant endocrine treatment of prostatic cancer with lymphatic metastasis?].
    Schröder FH
    Urologe A; 1991 Nov; 30(6):417-22. PubMed ID: 1722923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormonal therapy of prostatic carcinoma. Defining the challenge.
    Crawford ED
    Cancer; 1990 Sep; 66(5 Suppl):1035-8. PubMed ID: 2203516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stage D1 prostate cancer treated by radical prostatectomy and adjuvant hormonal treatment. Evidence for favorable survival in patients with DNA diploid tumors.
    Zincke H; Bergstralh EJ; Larson-Keller JJ; Farrow GM; Myers RP; Lieber MM; Barrett DM; Rife CC; Gonchoroff NJ
    Cancer; 1992 Jul; 70(1 Suppl):311-23. PubMed ID: 1600493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of prostate specific antigen in endocrine treatment for prostatic cancer.
    Arai Y; Yoshiki T; Yoshida O
    J Urol; 1990 Dec; 144(6):1415-9. PubMed ID: 1700155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Keyrole of endocrinology in the victory against prostate cancer].
    Labrie F
    Bull Cancer; 2006 Sep; 93(9):949-58. PubMed ID: 16980238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The timing and extent of androgen deprivation therapy for prostate cancer: weighing the clinical evidence.
    Ginzburg S; Albertsen PC
    Endocrinol Metab Clin North Am; 2011 Sep; 40(3):615-23, ix. PubMed ID: 21889724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of endocrine therapy for early and locally advanced prostate cancer.
    Wirth MP; Froehner M
    Drugs Aging; 2003; 20(2):115-24. PubMed ID: 12534312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.